RACK1 downregulation suppresses migration and proliferation of neuroblastoma cell lines

Oncology Reports

Volumn 27, Issue 5, 2012, Pages 1646-1652

  Lu, Fan ^a   Zhang, Chi ^a   Wu, Wen Jie ^a   Wu, Ye Ming ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Migration; Neuroblastoma; Proliferation; Receptors for activated C kinases

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MYC PROTEIN; PROTEIN KINASE B; PROTEIN TYROSINE KINASE; RECEPTOR FOR ACTIVATED C KINASE 1; RNA; SYNAPTOPHYSIN;

ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CELL TYPE; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE REPRESSION; GENE SILENCING; GENE TARGETING; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; PRIORITY JOURNAL; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, MYC; GENES, SRC; GTP-BINDING PROTEINS; HUMANS; NEOPLASM PROTEINS; NEUROBLASTOMA; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, CELL SURFACE;

EID: 84863281621     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.1629     Document Type: Article

References (29)

1. Maris JM, Hogarty MD, Bagatell R and Cohn SL: Neuroblastoma. Lancet 369: 2106-2120, 2007. (Pubitemid 46935947)
2. Modak S and Cheung NK: Neuroblastoma: therapeutic strategies for a clinical enigma. Cancer Treat Rev 36: 307-317, 2010.
3. Cotterill SJ, Pearson AD, Pritchard J, Foot AB, Roald B, Kohler JA and Imeson J: Clinical prognostic factors in 1277 patients with neuroblastoma: results of The European Neuroblastoma Study Group 'Survey' 1982-1992. Eur J Cancer 36: 901-908, 2000. (Pubitemid 30214141)
4. Grovas A, Fremgen A, Rauck A, Ruymann FB, Hutchinson CL, Winchester DP and Menck HR: The National Cancer Data Base report on patterns of childhood cancers in the United States. Cancer 80: 2321-2232, 1997.
5. Garaventa A, Parodi S, De Bernardi B, Dau D, Manzitti C, Conte M, Casale F, Viscardi E, Bianchi M, D'Angelo P, Zanazzo GA, Luksch R, Favre C, Tamburini A and Haupt R: Outcome of children with neuroblastoma after progression or relapse. A retrospective study of the Italian neuroblastoma registry. Eur J Cancer 45: 2835-2842, 2009.
6. Ara T and DeClerck YA: Mechanisms of invasion and metastasis in human neuroblastoma. Cancer Metastasis Rev 25: 645-657, 2006. (Pubitemid 46071869)
7. Zaizen Y, Taniguchi S and Suita S: The role of cellular motility in the invasion of human neuroblastoma cells with or without N-myc amplification and expression. J Pediatr Surg 33: 1765-1770, 1998. (Pubitemid 28565619)
8. Yoon KJ and Danks MK: Cell adhesion molecules as targets for therapy of neuroblastoma. Cancer Biol Ther 8: 306-311, 2009.
9. Mamidipudi V and Cartwright CA: A novel pro-apoptotic function of RACK1: suppression of Src activity in the intrinsic and Akt pathways. Oncogene 28: 4421-4433, 2009.
10. Dorn GW II and Mochly-Rosen D: Intracellular transport mechanisms of signal transducers. Annu Rev Physiol 64: 407-429, 2002.
11. Sklan EH, Podoly E and Soreq H: RACK1 has the nerve to act: structure meets function in the nervous system. Prog Neurobiol 78: 117-134, 2006. (Pubitemid 43290718)
12. Doan AT and Huttenlocher A: RACK1 regulates Src activity and modulates paxillin dynamics during cell migration. Exp Cell Res 313: 2667-2679, 2007. (Pubitemid 46992737)
13. Padanilam BJ and Hammerman MR: Ischemia-induced receptor for activated C kinase (RACK1) expression in rat kidneys. Am J Physiol 272: F160-F166, 1997.
14. Berns H, Humar R, Hengerer B, Kiefer FN and Battegay EJ: RACK1 is up-regulated in angiogenesis and human carcinomas. FASEB J 14: 2549-2558, 2000.
15. Hermanto U, Zong CS, Li W and Wang LH: RACK1, an insulin-like growth factor I (IGF-I) receptor-interacting protein, modulates IGF-I-dependent integrin signaling and promotes cell spreading and contact with extracellular matrix. Mol Cell Biol 22: 2345-2365, 2002. (Pubitemid 34224638)
16. Buensuceso CS, Woodside D, Huff JL, Plopper GE and O'Toole TE: The WD protein Rack1 mediates protein kinase C and integrin-dependent cell migration. J Cell Sci 114: 1691-1698, 2001. (Pubitemid 32454667)
17. Cao XX, Xu JD, Xu JW, Liu XL, Cheng YY, Wang WJ, Li QQ, Chen Q, Xu ZD and Liu XP: RACK1 promotes breast carcinoma proliferation and invasion/metastasis in vitro and in vivo. Breast Cancer Res Treat 123: 375-386, 2010.
18. Subauste MC, Ventura-Holman T, Du L, Subauste JS, Chan SL, Yu VC and Maher JF: RACK1 downregulates levels of the pro-apoptotic protein Fem1b in apoptosis-resistant colon cancer cells. Cancer Biol Ther 8: 2297-2305, 2009.
19. Cao XX, Xu JD, Liu XL, Xu JW, Wang WJ, Li QQ, Chen Q, Xu ZD and Liu XP: A superior independent predictor for poor clinical outcome in breast cancer. Int J Cancer 127: 1172-1179, 2010.
20. Savini I, D'Angelo I, Annicchiarico-Petruzzelli M, Bellincampi L, Melino G and Avigliano L: Ascorbic acid recycling in N-myc amplified human neuroblastoma cells. Anticancer Res 18: 819-822, 1998. (Pubitemid 28239600)
21. Burkhart CA, Cheng AJ, Madafiglio J, Kavallaris M, Mili M, Marshall GM, Weiss WA, Khachigian LM, Norris MD and Haber M: Effects of MYCN antisense oligonucleotide administration on tumorigenesis in a murine model of neuroblastoma. J Natl Cancer Inst 95: 1394-1403, 2003. (Pubitemid 37220459)
22. Kang JH, Rychahou PG, Ishola TA, Qiao J, Evers BM and Chung DH: MYCN silencing induces differentiation and apoptosis in human neuroblastoma cells. Biochem Biophys Res Commun 351: 192-197, 2006. (Pubitemid 44635425)
23. Opel D, Poremba C, Simon T, Debatin KM and Fulda S: Activation of Akt predicts poor outcome in neuroblastoma. Cancer Res 67: 735-745, 2007. (Pubitemid 46192214)
24. Chai H, Luo AZ, Weerasinghe P and Brown RE: Sorafenib downregulates ERK/Akt and STAT3 survival pathways and induces apoptosis in a human neuroblastoma cell line. Int J Clin Exp Pathol 3: 408-415, 2010.
25. Ryu SJ, Cho KA, Oh YS and Park SC: Role of Src-specific phosphorylation site on focal adhesion kinase for senescence-associated apoptosis resistance. Apoptosis 11: 303-313, 2006.
26. Brunton VG and Frame MC: Src and focal adhesion kinase as therapeutic targets in cancer. Curr Opin Pharmacol 8: 427-432, 2008.
27. Beierle EA, Ma X, Trujillo A, Kurenova EV, Cance WG and Golubovskaya VM: Inhibition of focal adhesion kinase and src increases detachment and apoptosis in human neuroblastoma cell lines. Mol Carcinog 49: 224-234, 2010.
28. Hishiki T, Saito T, Sato Y, Mitsunaga T, Terui E, Matsuura G, Saito E, Shibata R, Mise N, Yokoyama Y and Yoshida H: Src kinase family inhibitor PP2 induces aggregation and detachment of neuroblastoma cells and inhibits cell growth in a PI3 kinase/Akt pathway-independent manner. Pediatr Surg Int 27: 225-230, 2011.
29. Li Z, Tan F, Liewehr DJ, Steinberg SM and Thiele CJ: In vitro and in vivo inhibition of neuroblastoma tumor cell growth by AKT inhibitor perifosine. J Natl Cancer Inst 102: 758-770, 2010.